Tag nsclc [122 articles] Export

Recent papers classified by the tag nsclc.

	Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer. [My Copy] Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 14, No. 10. (15 May 2008), pp. 2895-2899. by Jeffrey A. Engelman, Pasi A. Jänne posted to tki review nsclc multidrug_resistance gefitinib englemann egfr by mat956 on 2009-11-28 21:09:41 as
	EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. [My Copy] The New England journal of medicine, Vol. 352, No. 8. (24 February 2005), pp. 786-792. by Susumu Kobayashi, Titus J. Boggon, Tajhal Dayaram, et al.Pasi A. Jänne, Olivier Kocher, Matthew Meyerson, Bruce E. Johnson, Michael J. Eck, Daniel G. Tenen, Balázs Halmos posted to tki nsclc multidrug_resistance kobayashi gefitinib egfr cancer by mat956 on 2009-11-28 16:11:47 as along with 1 person kokphinchooi
	Subdivision of the T1 Size Descriptor for Stage I Non-small Cell Lung Cancer Has Prognostic Value [My Copy] Chest, Vol. 136, No. 3. (September 2009), pp. 710-715. by Chao Ye, Justin R. Masterman, Mark S. Huberman, et al.Sidhu P. Gangadharan, Danielle C. McDonald, Michael S. Kent, Malcolm M. DeCamp posted to staging stage nsclc lung_cancer cancer by nicedoc on 2009-10-27 14:25:34 as
	The changing epidemiology of lung cancer with a focus on screening [My Copy] BMJ, Vol. 339, No. aug17_1. (17 August 2009), b3053. by Gerard A. Silvestri, Anthony J. Alberg, James Ravenel posted to nsclc non-small-cell-lung-cancer lung by m509396 on 2009-09-01 12:52:21 as along with 1 person b_chennell
	Gefitinib in advanced non-small cell lung cancer: does it deserve a second chance? [My Copy] The oncologist, Vol. 13, No. 9. (September 2008), pp. 933-944. by Thomas E. Stinchcombe, Mark A. Socinski posted to nsclc lung iressa gefitinib cancer by nicedoc on 2009-08-17 04:12:17 as
	Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non-Small-Cell Lung Cancer: AVAiL [My Copy] J Clin Oncol, Vol. 27, No. 8. (10 March 2009), pp. 1227-1234. by Martin Reck, Joachim von Pawel, Petr Zatloukal, et al.Rodryg Ramlau, Vera Gorbounova, Vera Hirsh, Natasha Leighl, Jorg Mezger, Venice Archer, Nicola Moore, Christian Manegold posted to nsclc by lrust on 2009-07-20 03:56:33 as
	First-Line Gefitinib for Patients With Advanced Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations Without Indication for Chemotherapy [My Copy] J Clin Oncol, Vol. 27, No. 9. (20 March 2009), pp. 1394-1400. by Akira Inoue, Kunihiko Kobayashi, Kazuhiro Usui, et al.Makoto Maemondo, Shoji Okinaga, Iwao Mikami, Masahiro Ando, Koichi Yamazaki, Yasuo Saijo, Akihiko Gemma, Hitoshi Miyazawa, Tomoaki Tanaka, Kenji Ikebuchi, Toshihiro Nukiwa, Satoshi Morita, Koichi Hagiwara posted to nsclc by lrust on 2009-07-20 03:46:40 as
	The "Lazarus Response" in Treatment-Naive, Poor Performance Status Patients With Non-Small-Cell Lung Cancer and Epidermal Growth Factor Receptor Mutation [My Copy] J Clin Oncol, Vol. 27, No. 9. (20 March 2009), pp. 1350-1354. by Corey J. Langer posted to nsclc by lrust on 2009-07-20 03:36:22 as
	Phase III Study of Immediate Compared With Delayed Docetaxel After Front-Line Therapy With Gemcitabine Plus Carboplatin in Advanced Non-Small-Cell Lung Cancer [My Copy] J Clin Oncol, Vol. 27, No. 4. (1 February 2009), pp. 591-598. by Panos M. Fidias, Shaker R. Dakhil, Alan P. Lyss, et al.David M. Loesch, David M. Waterhouse, Jane L. Bromund, Ruqin Chen, Maria Hristova-Kazmierski, Joseph Treat, Coleman K. Obasaju, Martin Marciniak, John Gill, Joan H. Schiller posted to nsclc by lrust on 2009-07-20 03:20:45 as
	Association Between Estrogen Receptor-beta Expression and Epidermal Growth Factor Receptor Mutation in the Postoperative Prognosis of Adenocarcinoma of the Lung [My Copy] J Clin Oncol, Vol. 27, No. 3. (20 January 2009), pp. 411-417. by Naohiro Nose, Kenji Sugio, Tsunehiro Oyama, et al.Tadahiro Nozoe, Hidetaka Uramoto, Teruo Iwata, Takamitsu Onitsuka, Kosei Yasumoto posted to nsclc by lrust on 2009-07-20 03:00:07 as
	EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues. [My Copy] The American journal of pathology, Vol. 174, No. 2. (1 February 2009), pp. 661-670. by Maria Paola P. Martelli, Gabriella Sozzi, Luis Hernandez, et al.Valentina Pettirossi, Alba Navarro, Davide Conte, Patrizia Gasparini, Federica Perrone, Piergiorgio Modena, Ugo Pastorino, Antonino Carbone, Alessandra Fabbri, Angelo Sidoni, Shigeo Nakamura, Marcello Gambacorta, Pedro Luis L. Fernández, Jose Ramirez, John K. Chan, Walter Franco F. Grigioni, Elias Campo, Stefano A. Pileri, Brunangelo Falini posted to cancer eml4-alk lung lungcancer nsclc by holympus on 2009-06-15 15:11:49 as
	Clinical Model to Predict Survival in Chemonaive Patients With Advanced Non-Small-Cell Lung Cancer Treated With Third-Generation Chemotherapy Regimens Based on Eastern Cooperative Oncology Group Data [My Copy] J Clin Oncol, Vol. 23, No. 1. (1 January 2005), pp. 175-183. by Tien Hoang, Ronghui Xu, Joan H. Schiller, Philip Bonomi, David H. Johnson posted to nsclc by lrust on 2009-05-22 20:45:10 as
	Treatment of Advanced Non-Small-Cell Lung Cancer in the Elderly: Results of an International Expert Panel [My Copy] J Clin Oncol, Vol. 23, No. 13. (1 May 2005), pp. 3125-3137. by Cesare Gridelli, Matti Aapro, Andrea Ardizzoni, et al.Lodovico Balducci, Filippo De Marinis, Karen Kelly, Thierry Le Chevalier, Christian Manegold, Francesco Perrone, Rafael Rosell, Frances Shepherd, Luigi De Petris, Massimo Di Maio, Corey Langer posted to nsclc by lrust on 2009-05-22 20:43:52 as
	Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non-Small-Cell Lung Cancer: A Multicenter Phase II Trial [My Copy] J Clin Oncol, Vol. 21, No. 9. (1 May 2003), pp. 1752-1759. by Daniel C. Betticher, Hsu, Martin Totsch, et al.Eva Hansen, Christine Joss, Christian von Briel, Ralph A. Schmid, Miklos Pless, James Habicht, Arnaud D. Roth, Anastase Spiliopoulos, Rolf Stahel, Walter Weder, Roger Stupp, Fritz Egli, Markus Furrer, Hanspeter Honegger, Martin Wernli, Thomas Cerny, Hans-Beat Ris posted to nsclc by lrust on 2009-05-22 20:40:06 as
	Consolidation Docetaxel After Concurrent Chemoradiotherapy in Stage IIIB Non-Small-Cell Lung Cancer: Phase II Southwest Oncology Group Study S9504 [My Copy] J Clin Oncol, Vol. 21, No. 10. (15 May 2003), pp. 2004-2010. by David R. Gandara, Kari Chansky, Kathy S. Albain, et al.Bryan R. Leigh, Laurie E. Gaspar, Primo N. Lara, Howard Burris, Paul Gumerlock, Philip J. Kuebler, James D. Bearden, John Crowley, Robert Livingston posted to nsclc by lrust on 2009-05-22 20:38:58 as
	Randomized, Multinational, Phase III Study of Docetaxel Plus Platinum Combinations Versus Vinorelbine Plus Cisplatin for Advanced Non-Small-Cell Lung Cancer: The TAX 326 Study Group [My Copy] J Clin Oncol, Vol. 21, No. 16. (15 August 2003), pp. 3016-3024. by Frank Fossella, Jose R. Pereira, Joachim von Pawel, et al.Anna Pluzanska, Vera Gorbounova, Eckhard Kaukel, Karin V. Mattson, Rodryg Ramlau, Aleksandra Szczesna, Panagiotis Fidias, Michael Millward, Chandra P. Belani posted to nsclc by lrust on 2009-05-22 20:35:31 as
	Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805 [My Copy] J Clin Oncol, Vol. 13, No. 8. (1 August 1995), pp. 1880-1892. by K. S. Albain, V. W. Rusch, J. J. Crowley, et al.T. W. Rice, At Turrisi, J. K. Weick, V. A. Lonchyna, C. A. Presant, R. J. Mckenna, D. R. Gandara posted to nsclc by lrust on 2009-05-22 20:33:49 as
	Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non-Small-Cell Lung Cancer [My Copy] J Clin Oncol, Vol. 26, No. 21. (20 July 2008), pp. 3543-3551. by Giorgio V. Scagliotti, Purvish Parikh, Joachim von Pawel, et al.Bonne Biesma, Johan Vansteenkiste, Christian Manegold, Piotr Serwatowski, Ulrich Gatzemeier, Raghunadharao Digumarti, Mauro Zukin, Jin S. Lee, Anders Mellemgaard, Keunchil Park, Shehkar Patil, Janusz Rolski, Tuncay Goksel, Filippo de Marinis, Lorinda Simms, Katherine P. Sugarman, David Gandara posted to nsclc by lrust on 2009-05-22 20:28:21 as
	Monitoring Tumor Glucose Utilization by Positron Emission Tomography for the Prediction of Treatment Response to Epidermal Growth Factor Receptor Kinase Inhibitors [My Copy] Clinical Cancer Research, Vol. 12, No. 19. (1 October 2006), pp. 5659-5667. by Helen Su, Claudia Bodenstein, Rebecca A. Dumont, et al.Yann Seimbille, Steven Dubinett, Michael E. Phelps, Harvey Herschman, Johannes Czernin, Wolfgang Weber posted to nsclc by yuchuanwang on 2009-05-11 20:55:18 as along with 1 person mandres80
	Fluorodeoxyglucose positron emission tomography and tumor marker expression in non-small cell lung cancer [My Copy] J Thorac Cardiovasc Surg, Vol. 137, No. 1. (1 January 2009), pp. 43-48. by Matthew D. Taylor, Philip W. Smith, William K. Brix, et al.Mark R. Wick, Nicholas Theodosakis, Brian R. Swenson, Benjamin D. Kozower, Christine L. Lau, David R. Jones posted to nsclc by yuchuanwang on 2009-05-11 20:43:55 as
	Comparative evaluation of FET and FDG for differentiating lung carcinoma from inflammation in mice. [My Copy] Anticancer research, Vol. 26, No. 2A. (r 2006), pp. 917-925. by C. H. Chang, H. E. Wang, S. Y. Wu, et al.K. H. Fan, T. H. Tsai, T. W. Lee, S. R. Chang, R. S. Liu, C. F. Chen, C. H. Chen, Y. K. Fu posted to nsclc by yuchuanwang on 2009-05-11 20:24:59 as
	Prognostic value of fluorodeoxyglucose positron emission tomography in non-small cell lung cancer: a review. [My Copy] Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, Vol. 1, No. 2. (February 2006), pp. 152-159. by G. Pillot, B. A. Siegel, R. Govindan posted to nsclc by yuchuanwang on 2009-05-11 20:22:54 as
	Phase IB trial of oral talactoferrin in the treatment of patients with metastatic solid tumors [My Copy] Investigational New Drugs by Teresa Hayes, Gerald Falchook, Atul Varadhachary posted to cancer lactoferrin lung lungcancer nsclc talactoferrin by holympus on 2009-04-26 11:04:42 as
	Effect of krestin (PSK) as adjuvant treatment on the prognosis after radical radiotherapy in patients with non-small cell lung cancer. [My Copy] Anticancer research, Vol. 13, No. 5C. (t 1993), pp. 1815-1820. by K. Hayakawa, N. Mitsuhashi, Y. Saito, et al.M. Takahashi, S. Katano, K. Shiojima, M. Furuta, H. Niibe posted to cancer krestin lung lungcancer nsclc polysaccharide progressionfreesurvival psk survival by holympus on 2009-04-22 22:38:58 as
	Traditional Chinese medicine Astragalus reverses predominance of Th2 cytokines and their up-stream transcript factors in lung cancer patients. [My Copy] Oncology reports, Vol. 10, No. 5. (t 2003), pp. 1507-1512. by H. Wei, R. Sun, W. Xiao, et al.J. Feng, C. Zhen, X. Xu, Z. Tian posted to astragalus cancer lung lungcancer nsclc by holympus on 2009-04-22 02:18:25 as
	Anti-cachectic effect of clarithromycin for patients with unresectable non-small cell lung cancer. [My Copy] Chemotherapy, Vol. 47, No. 6. (December 2001), pp. 444-451. by M. Sakamoto, K. Mikasa, T. Majima, et al.K. Hamada, M. Konishi, K. Maeda, E. Kita, N. Narita posted to cachexia cancer clarithromycin lung lungcancer nsclc by holympus on 2009-04-21 21:51:37 as
	[Effect of clarithromycin treatment of natural killer cell activity in patients with advanced non-small cell lung cancer] [My Copy] Gan to kagaku ryoho. Cancer & chemotherapy, Vol. 25, No. 14. (December 1998), pp. 2259-2266. by M. Sakamoto, K. Mikasa, K. Hamada, et al.M. Konishi, K. Maeda, E. Yoshimoto, K. Ueda, T. Majima, M. Sawaki, E. Kita, N. Narita posted to cancer clarithromycin lung lungcancer naturalkiller nsclc by holympus on 2009-04-21 21:49:46 as
	Adjuvant effect of clarithromycin on chemotherapy for murine lung cancer. [My Copy] Chemotherapy, Vol. 46, No. 1. (b 2000), pp. 49-61. by K. Hamada, K. Mikasa, Y. Yunou, et al.T. Kurioka, T. Majima, N. Narita, E. Kita posted to cancer chemotherapy clarithromycin lung lungcancer nsclc by holympus on 2009-04-21 21:47:54 as
	Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer (Review). [My Copy] Oncology reports, Vol. 12, No. 5. (November 2004), pp. 955-965. by G. Wang, E. Reed, Q. Q. Li posted to cancer chemotherapy cisplatin lung lungcancer nsclc by holympus on 2009-04-21 20:46:55 as
	Curcumin enhances Vinorelbine mediated apoptosis in NSCLC cells by the mitochondrial pathway. [My Copy] Biochemical and biophysical research communications, Vol. 331, No. 4. (17 June 2005), pp. 1245-1252. by S. Sen, H. Sharma, N. Singh posted to apoptosis cancer chemotherapy curcumin lung lungcancer nsclc vinorelbine by holympus on 2009-04-21 18:10:09 as
	The current situation: erlotinib (Tarceva) and gefitinib (Iressa) in non-small cell lung cancer. [My Copy] The oncologist, Vol. 10, No. 7. (August 2005), pp. 467-470. by R. L. Comis posted to cancer erlotinib gerifinib iressa lung lungcancer nsclc tarceva by holympus on 2009-04-21 15:43:49 as
	A phase I trial to determine the optimal biological dose of celecoxib when combined with erlotinib in advanced non-small cell lung cancer. [My Copy] Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 12, No. 11 Pt 1. (1 June 2006), pp. 3381-3388. by K. L. Reckamp, K. Krysan, J. D. Morrow, et al.G. L. Milne, R. A. Newman, C. Tucker, R. M. Elashoff, S. M. Dubinett, R. A. Figlin posted to cancer celecoxib erlotinib lung lungcancer nsclc tarceva by holympus on 2009-04-21 15:40:51 as
	Randomized Phase II Trial of Sequential Chemotherapy in Advanced Non-Small Cell Lung Cancer (SWOG 9806): Carboplatin/Gemcitabine followed by Paclitaxel or Cisplatin/Vinorelbine followed by Docetaxel [My Copy] Clin Cancer Res, Vol. 10, No. 15. (1 August 2004), pp. 5022-5026. by Martin J. Edelman, Joseph I. Clark, Kari Chansky, et al.Kathy Albain, Nirmala Bhoopalam, Geoffrey R. Weiss, Jeffrey K. Giguere, Karen Kelly, John Crowley, David R. Gandara posted to cancer carboplatin cisplatin clinical docetaxel gemcitabine lung lungcancer nsclc paclitaxel randomized vinorelbine by holympus on 2009-04-21 15:11:27 as
	Multimodality therapy in stage III non-small cell lung cancer. [My Copy] The Annals of thoracic surgery, Vol. 61, No. 5. (May 1996), pp. 1564-1572. by M. J. Edelman, D. R. Gandara, M. Roach, J. R. Benfield posted to cancer lung lungcancer multimodal nsclc by holympus on 2009-04-21 15:09:09 as
	New directions in the treatment of non-small cell lung cancer: an overview. [My Copy] The oncologist, Vol. 6 Suppl 1 (2001), pp. 1-3. by M. J. Edelman posted to cancer lung lungcancer nsclc by holympus on 2009-04-21 15:07:26 as
	Long-term survival cases of lung cancer presented as solitary bone metastasis. [My Copy] Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia, Vol. 11, No. 6. (December 2005), pp. 401-404. by Y. Hirano, M. Oda, Y. Tsunezuka, N. Ishikawa, G. Watanabe posted to cancer lung lungcancer metastasis nsclc survival by holympus on 2009-04-21 14:57:55 as
	Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials. [My Copy] J Clin Oncol, Vol. 24, No. 3. (20 January 2006), pp. 419-430. by M. McCulloch, C. See, X. J. Shu, et al.M. Broffman, A. Kramer, W. Y. Fan, J. Gao, W. Lieb, K. Shieh, J. M. Colford posted to astragalus cancer chemotherapy clinical lung lungcancer nsclc by holympus on 2009-04-21 14:45:28 as along with 1 person and 1 group anihawkinson Nutritional_Polymorphisms
	Considerations for second-line therapy of non-small cell lung cancer. [My Copy] The oncologist, Vol. 13 Suppl 1 (2008), pp. 28-36. by T. E. Stinchcombe, M. A. Socinski posted to cancer chemotherapy lung lungcancer nsclc overallsurvival progressionfreesurvival second-line survival by holympus on 2009-04-21 13:39:58 as
	Optimal duration of chemotherapy in advanced non-small cell lung cancer. [My Copy] Current treatment options in oncology, Vol. 8, No. 1. (February 2007), pp. 38-46. by M. B. Lustberg, M. J. Edelman posted to cancer clinical lung lungcancer nsclc randomized by holympus on 2009-04-21 13:33:00 as
	Chemotherapeutic management of stage IV non-small cell lung cancer. [My Copy] Chest, Vol. 123, No. 1 Suppl. (January 2003) by M. A. Socinski, D. E. Morris, G. A. Masters, R. Lilenbaum, posted to cancer clinical lung lungcancer nsclc randomized by holympus on 2009-04-21 13:19:42 as
	Coriolus versicolor polysaccharide peptide slows progression of advanced non-small cell lung cancer. [My Copy] Respiratory medicine, Vol. 97, No. 6. (June 2003), pp. 618-624. by K. W. Tsang, C. L. Lam, C. Yan, et al.J. C. Mak, G. C. Ooi, J. C. Ho, B. Lam, R. Man, J. S. Sham, W. K. Lam posted to cancer clinical double-blind lung lungcancer nsclc polysaccharide psp randomized by holympus on 2009-04-20 05:27:52 as
	The use of mushroom glucans and proteoglycans in cancer treatment. [My Copy] Alternative medicine review : a journal of clinical therapeutic, Vol. 5, No. 1. (February 2000), pp. 4-27. by P. M. Kidd posted to beta-glucan cancer clinical colon coloncancer colorectal krestin lung lungcancer nsclc polysaccharide psk randomized by holympus on 2009-04-20 05:21:11 as
	Effect of Krestin as adjuvant treatment following radical radiotherapy in non-small cell lung cancer patients. [My Copy] Cancer detection and prevention, Vol. 21, No. 1. (1997), pp. 71-77. by K. Hayakawa, N. Mitsuhashi, Y. Saito, et al.Y. Nakayama, M. Furuta, S. Nakamoto, M. Kawashima, H. Niibe posted to cancer krestin lung lungcancer nsclc psk by holympus on 2009-04-20 05:04:47 as
	Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. [My Copy] The Journal of clinical investigation, Vol. 97, No. 12. (15 June 1996), pp. 2792-2802. by D. A. Arenberg, S. L. Kunkel, P. J. Polverini, M. Glass, M. D. Burdick, R. M. Strieter posted to angiogenesis cancer il-8 il8 lung lungcancer metastasis mice nsclc tumorgrowth chemokines neovascularization by holympus on 2009-04-09 08:39:45 as
	Phase III Study of Cisplatin, Etoposide, and Concurrent Chest Radiation With or Without Consolidation Docetaxel in Patients With Inoperable Stage III Non-Small-Cell Lung Cancer: The Hoosier Oncology Group and U.S. Oncology [My Copy] J Clin Oncol, Vol. 26, No. 35. (10 December 2008), pp. 5755-5760. by Nasser Hanna, Marcus Neubauer, Constantin Yiannoutsos, et al.Ronald Mcgarry, James Arseneau, Rafat Ansari, Craig Reynolds, Ramaswamy Govindan, Anton Melnyk, William Fisher, Donald Richards, Daniel Bruetman, Thomas Anderson, Naveed Chowhan, Sreenivasa Nattam, Prasad Mantravadi, Cynthia Johnson, Tim Breen, Angela White, Lawrence Einhorn posted to nsclc by lrust on 2009-03-02 01:39:52 as
	Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975. [My Copy] Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Vol. 17, No. 11. (November 2006), pp. 1698-1704. by F. Efficace, A. Bottomley, E. F. Smit, et al.P. Lianes, C. Legrand, C. Debruyne, F. Schramel, H. J. Smit, R. Gaafar, B. Biesma, C. Manegold, C. Coens, G. Giaccone, J. Van Meerbeeck, posted to 08975 clinical eortc medical nsclc qol trial by catherinelegrand on 2009-02-26 07:47:23 as
	Lessons to learn from EORTC study 08981: a feasibility study of induction chemoradiotherapy followed by surgical resection for stage IIIB non-small cell lung cancer. [My Copy] Lung cancer (Amsterdam, Netherlands), Vol. 55, No. 1. (January 2007), pp. 95-99. by V. Surmont, R. J. van Klaveren, C. Goor, et al.F. Schramel, C. Manegold, C. Legrand, P. Van Schil, J. P. Van Meerbeeck posted to 08981 clinical eortc feasibility medical nsclc trial by catherinelegrand on 2009-02-26 07:45:44 as
	Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973). [My Copy] European journal of cancer (Oxford, England : 1990), Vol. 43, No. 1. (January 2007), pp. 114-121. by J. Belderbos, L. Uitterhoeve, N. van Zandwijk, et al.H. Belderbos, P. Rodrigus, P. van de Vaart, A. Price, N. van Walree, C. Legrand, S. Dussenne, H. Bartelink, G. Giaccone, C. Koning, posted to 08972 clinical eortc medical nsclc trial by catherinelegrand on 2009-02-26 07:44:38 as
	Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. [My Copy] Journal of the National Cancer Institute, Vol. 99, No. 6. (21 March 2007), pp. 442-450. by J. P. van Meerbeeck, G. W. Kramer, P. E. Van Schil, et al.C. Legrand, E. F. Smit, F. Schramel, V. C. Tjan-Heijnen, B. Biesma, C. Debruyne, N. van Zandwijk, T. A. Splinter, G. Giaccone, posted to 08941 clinical eortc medical nsclc randomized trial by catherinelegrand on 2009-02-26 07:38:12 as
	Early detection of erlotinib treatment response in NSCLC by 3'-deoxy-3'-[F]-fluoro-L-thymidine ([F]FLT) positron emission tomography (PET). [My Copy] PLoS ONE, Vol. 3, No. 12. (2008) by R. T. Ullrich, T. Zander, B. Neumaier, et al.M. Koker, T. Shimamura, Y. Waerzeggers, C. L. Borgman, S. Tawadros, H. Li, M. L. Sos, H. Backes, G. I. Shapiro, J. Wolf, A. H. Jacobs, R. K. Thomas, A. Winkeler posted to flt nsclc pet preclinical by yuchuanwang on 2009-02-02 16:45:11 as along with 1 person xtizon

Note: You may cite this page as: http://www.citeulike.org/tag/nsclc

Result page: 1 2 3 Next

egfr	35
lung	29
cancer	28
lungcancer	23
iressa	20
inhibitor	17
eml4-alk	15
mutation	14
review	13
clinical	10
gefitinib	10
randomized	6
chemotherapy	5
erbb2	5
erlotinib	5
amplification	4
c225	4
eortc	4
erbb3	4
medical	4
oncology	4
survival	4
tarceva	4
trial	4
akt	3
clarithromycin	3
krestin	3
locallyadvanced	3
polysaccharide	3
psk	3
tki	3
xrt	3
activation	2
angiogenesis	2
apoptosis	2
astragalus	2
cisplatin	2
erbb	2
genomics	2
her2	2
hki-272	2
met	2
metastasis	2
multidrug_resistance	2
novel	2
phase3	2
postop	2
progressionfreesurvival	2
stat3	2
t790m	2
vinorelbine	2
08941	1
08972	1
4dct_scans	1
cachexia	1
calgb	1
chart	1
chemokines	1
colon	1
colorectal	1
deletion	1
dosimetrics	1
double-blind	1
egf	1
egf-independent	1
gemcitabine	1
gerifinib	1
hematology	1
herceptin	1
il-8	1
il8	1
inhibito	1
iress	1
ligand	1
mediastinallymphnode	1
meta-analysis	1
mice	1
minimal-irradiation	1
mw	1
neovascularization	1
non-small-cell-lung-cancer	1
normaltissue	1
p53	1
pet	1
psp	1
pten	1
pulmonary	1
qol	1
radiation-induced-esophagitis	1
radiotx	1
resistance	1
rgr	1
second-line	1
seer	1
staging	1
swog	1
talactoferrin	1
tnf	1
tumours	1
v3	1

Tag nsclc [122 articles] Export

Related Tags